Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Rite Aid Corporation (RAD), Sprint Nextel Corporation (S): A Look At A Few Of Today’s Mega-Movers

Editor’s note: Related tickers: Rite Aid Corporation (NYSE:RAD), Sprint Nextel Corporation (NYSE:S), Pfizer Inc. (NYSE:PFE), Sirius XM Radio Inc (NASDAQ:SIRI).

At the end of the week, we should take a look back and notice the performance of several stocks. They include: Rite Aid Corporation (NYSE:RAD)Sprint Nextel Corporation (NYSE:S), Pfizer Inc. (NYSE:PFE), and Sirius XM Radio Inc (NASDAQ:SIRI).

Rite Aid Corporation (NYSE:RAD)

Rite Aid Corporation (NYSE:RAD) was one of the big movers on the market during the week. The stock gained 29.78% over the past five days and closed on Friday 8.96% higher at $2.31 in turnover worth about $59 million, the second largest on NYSE. Rite Aid Corporation (NYSE:RAD) advanced mainly on Thursday, when the company published its results for the fourth quarter of 2012 as well as for the full year of 2012. In this way, Rite Aid Corporation (NYSE:RAD)’s net income for 2012 totaled $118.1 million or $0.12 per diluted share. “In addition to setting a new company record for full-year Adjusted EBITDA [$1,128.4 million], we generated full-year net income for the first time since fiscal 2007,” Rite Aid Corporation (NYSE:RAD) quoted its Chairman, President and CEO, John Standley in a statement.

Sprint Nextel Corporation (NYSE:S) edged down by 0.16% over the week and ended 0.64% lower at $6.22 on Friday, with turnover worth almost $46 million, the third largest on NYSE. Zolmax News quoted Stock Rating that JP Morgan Chase analysts have reaffirmed the “neutral” rating for Sprint Nextel Corporation (NYSE:S), having the target price set at $6.00. Also, reported that Sprint Nextel Corporation (NYSE:S) is thinking about extending the customer base in Indiana and California by launching LTE network in these states.

A growth was also experienced by Pfizer Inc. (NYSE:PFE), which advanced by 5.4% over the week and inched up by 0.1% to $30.67 in deals worth $39.1 million on Friday. In a press release issued on Wednesday, Pfizer Inc. (NYSE:PFE) announced about its investigational compound palbociclib, which has got Breakthrough Therapy designation by the FDA for the potential treatment of patients with breast cancer.  “We appreciate the opportunity that Breakthrough Therapy designation provides to work closely with the FDA on the development of palbociclib, […] Palbociclib is one example of Pfizer Inc. (NYSE:PFE)’s commitment to identifying and translating innovative science into meaningful new treatment options for cancer patients,” the statement quoted  Dr. Mace Rothenberg, senior vice president of clinical development and medical affairs for Pfizer Inc. (NYSE:PFE)’s Oncology business unit.

Sirius XM Radio Inc (NASDAQ:SIRI) increased by 2.33% during the past five days and lost 2.38% to $3.08 in turnover worth about $37.8 million on Friday. Sirius XM Radio Inc (NASDAQ:SIRI) is planning to release its first quarter results on April 30. Analyst Jason Basinet from Citi Research Equities said that Sirius XM Radio Inc (NASDAQ:SIRI) will not initiate a transformative acquisition to expand its telematic service offerings due to the large costs of acquisition, but will rather “invest in the telematic segment to fill in missing capabilities through organic investments augmented by targeted, low-cost acquisitions instead of a transformative acquisition,” according to ValueWalk.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!